International trends in asthma mortality

CIBA Foundation Symposia

Volumn , Issue 206, 1997, Pages 140-156

  Beasley, Richard ^a   Pearce, Neil ^a   Crane, Julian ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; HEALTH; HUMAN; MORTALITY; NEW ZEALAND; REVIEW;

ASTHMA; HUMANS; NEW ZEALAND; WORLD HEALTH;

EID: 0030627605     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Baumann A, Lee S 1990 Trends in asthma mortality in Australia, 1911-1986. Med J Aust 153:366
2. Beasley R, Smith K, Pearce N, Crane J, Burgess C, Culling C 1990 Trends in asthma mortality in New Zealand, 1908-1986. Med J Aust 152:570-573
3. Beasley R, Pearce N, Crane J, Windom H, Burgess C 1991 Asthma mortality and inhaled beta agonist therapy. Aust NZ J Med 21:753-763
4. Beasley R, Burgess C, Pearce N, Grainger J, Crane J 1994 Confounding by severity does not explain the association between ferioterol and asthma death. Clin Exp Allergy 24:660-668
5. Bremner P, Siebers R, Crane J, Pearce N, Beasley R, Burgess C 1996 Partial versus full beta receptor agonism - a clinical study of inhaled albuterol and fenoterol. Chest 109:957-962
6. Collins JM, McDevitt DG, Shanks RG et al 1969 The cardiotoxicity of isoprenaline during hypoxia. Br J Pharmacol 36:35-45
7. Crane J, Pearce N, Flatt A et al 1989 Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet 1:917-922
8. Criee C-P, Quast CH, Ludtke R, Laier-Groeneveld G, Huttemann U 1993 Use of beta agonists and mortality in patients with stable COPD. Eur Resp J 6:426S
9. Ernst P, Spitzer WO, Suissa S et al 1992 Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 268:3462-3464
10. Fraser PM, Speizer FE, Waters DM et al 1971 The circumstances preceding death from asthma in young people in 1968 to 1969. Br J Dis Chest 65:71-84
11. Grainger J, Woodman K, Pearce N et al 1991 Prescribed fenoterol and death from asthma in New Zealand, 1981-1987: a further case-control study. Thorax 46:105-111
12. Haahtela T, Lindholm H, Björkstén F, Koskenvuo K, Laitinen LA 1990 Prevalence of asthma in Finnish young men. Br Med J 301:266-268
13. Hensley MJ 1992 Fenoterol and death from asthma. Med J Aust 156:882
14. Jackson RT, Beaglehole P, Rea HH et al 1982 Mortality from asthma: a new epidemic in New Zealand. Br Med J 28:7715-7745
15. Jackson R, Sears MR, Beaglehole R et al 1988 International trends in asthma mortality: 1970 to 1985. Chest 94:914-918
16. Mitchell EA 1985 International trends in hospital admission rates for asthma. Arch Dis Child 60:376-378
17. Mitsui S 1986 Death from bronchial asthma in Japan. Sino-Jpn J Allergol Immunol Soshiran 3:249-257
18. National Institutes of Health 1995 Epidemiology. In: Global Initiative for Asthma: global strategy for asthma management and prevention (National Institutes of Health, National Heart, Lung and Blood Institute and World Health Organisation Workshop Report). NIH publication no. 95-3659, p 10-24
19. Osler W 1901 The principles and practice of medicine, 4th edn. Pentland, Edinburgh
20. Pearce N, Grainger J, Atkinson M et al 1990 Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-1981. Thorax 45:170-175
21. Pearce NE, Crane J, Burgess C, Jackson R, Beasley R 1991 Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy 21:401-410
22. Pearce N, Weiland S, Keil U et al 1993 Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol. Eur Resp J 6:1455-1461
23. Pearce N, Beasley R, Crane J, Burgess C, Jackson R 1995 End of the New Zealand asthma mortality epidemic. Lancet 345:41-44
24. Sackett DL, Shannon HS, Browman GW 1990 Fenoterol and fatal asthma. Lancet I:46
25. Sears MR 1991 Worldwide trends in asthma mortality. Bull Int Union Tuberc Lung Dis 66:79-83
26. 2-agonist controversy: observations, explanations and relationship to epidemiology. Drug Safety 11:259-283
27. Speizer FE, Doll R 1968 A century of asthma deaths in young people. Br Med J 3:245-246
28. Speizer FE, Doll R, Heaf P 1968 Observations on recent increases in mortality from asthma. Br Med J 1:335-339
29. Spitzer WD, Suissa S, Ernst P et al 1992 The use of beta agonists and the risk of death and near death from asthma. New Engl J Med 326:501-506
30. Stolley PD 1972 Why the United States was spared an epidemic of deaths due to asthma. Am Rev Resp Dis 105:883-890
31. Stolley PD, Schinnar R 1978 Association between asthma mortality and isoproterenol aerosols: a review. Prev Med 7:319-338
32. Suissa S 1995 The case-time-control design. Epidemiology 6:248-253
33. Taylor DR, Sears MR 1994 Regular beta-adrenergic agonists: evidence, not reassurance, is what is needed. Chest 106:552-559
34. Toogood JH, Jennings BH, Baskerville JC, Lefcoe NM 1993 Aerosol corticosteroids. In: Weis ED, Stein M (eds) Bronchial asthma: mechanisms and therapeutics, 3rd edn. Little, Brown & Co, Boston, p 818-841
35. Trembath PW, Greenacre JK, Anderson M et al 1979 Comparison of four weeks treatment with fenoterol and terbutaline aerosols in adult asthmatics. J Allergy Clin Immunol 63:395-400
36. Weiss KB, Wagener DK 1990 Changing patterns of asthma mortality: identifying populations at high risk. JAMA 264:1683-1687